NDMA estimates that over 30% of national OTC brand name products and 95% of store brand packages have small sizes or nontraditional shapes that aren't big enough to permit regulatory copy in 6-point type. Drug manufacturers, NDMA said, are doing their best to maximize type size without going below 4.5-point type.
Type too small?
The Nonprescription Drug Manufacturers Assn. (NDMA) supports FDA's attempt to simplify OTC drug labels but called for greater flexibility in the proposed 6-point type size requirement.
Aug 31, 1997
Recommended
Recommended
Machinery Basics
Annual Outlook Report: Sustainability
The road ahead for CPGs in 2025 and beyond—<i>Packaging World</i> editors review key findings from a survey of 88 brand owners, CPG, and FMCG readers.
Download Now
Is your palletizing solution leaving money on the floor?
Discover which palletizing technology—robotic, conventional, or hybrid—will maximize your packaging line efficiency while minimizing long-term costs in this comprehensive analysis.
Read More
